120 related articles for article (PubMed ID: 23487902)
1. Championing consumers. Leibowitz talks of challenging patent agreements, role of antitrust enforcement. Interview by Joe Carlson.
Leibowitz J
Mod Healthc; 2013 Feb; 43(6):18-9. PubMed ID: 23487902
[No Abstract] [Full Text] [Related]
2. Unsettling drug patent settlements: a framework for presumptive illegality.
Carrier MA
Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
[TBL] [Abstract][Full Text] [Related]
3. FTC to doctors: price fixing won't fly. Interview by Wayne J Guglielmo.
Brennan JW
Med Econ; 2003 May; 80(9):85-6, 89. PubMed ID: 12776619
[No Abstract] [Full Text] [Related]
4. Back to the future. Muris returns with renewed interest in enforcement.
Taylor M
Mod Healthc; 2003 Feb; 33(7):27-8. PubMed ID: 12688088
[No Abstract] [Full Text] [Related]
5. Chance for change. FTC to target monopolies in court.
Carlson J
Mod Healthc; 2012 Jul; 42(29):14. PubMed ID: 22852489
[No Abstract] [Full Text] [Related]
6. Pharmaceutical patent settlements: the antitrust risks.
Balto DA
Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464
[No Abstract] [Full Text] [Related]
7. AMA to the FTC: level the playing field.
Palmisano DJ
Med Econ; 2003 May; 80(9):86. PubMed ID: 12862059
[No Abstract] [Full Text] [Related]
8. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
Paine CS
Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
[No Abstract] [Full Text] [Related]
9. The Role of Regulatory Agencies and Intellectual Property: Part II.
Noonan KE
Cold Spring Harb Perspect Med; 2015 Mar; 5(7):a020834. PubMed ID: 25775920
[TBL] [Abstract][Full Text] [Related]
10. Federal Trade Commission antitrust enforcement in the dental profession.
Ragan MR
J Law Ethics Dent; 1990; 3():5-11. PubMed ID: 2098529
[No Abstract] [Full Text] [Related]
11. Getting back in the game. FTC, Justice Department step up scrutiny of antitrust issues in healthcare, including a look at mergers past and present.
Taylor M
Mod Healthc; 2003 Feb; 33(7):26-31, 34. PubMed ID: 12688087
[No Abstract] [Full Text] [Related]
12. Enforcing reform. It's time for federal authorities to bring antitrust scrutiny to insurers.
Balto D
Mod Healthc; 2010 May; 40(21):24. PubMed ID: 20540212
[No Abstract] [Full Text] [Related]
13. Recent FTC settlements remind us about antitrust rules.
Schulte DJ
J Mich Dent Assoc; 2014 Apr; 96(4):20, 67. PubMed ID: 24968607
[No Abstract] [Full Text] [Related]
14. The Federal Trade Commission and physician practice.
Graham J
J Med Pract Manage; 2005; 20(5):259-62. PubMed ID: 15921139
[TBL] [Abstract][Full Text] [Related]
15. "Pay for delay" settlements of disputes over pharmaceutical patents.
Kesselheim AS; Murtagh L; Mello MM
N Engl J Med; 2011 Oct; 365(15):1439-45. PubMed ID: 21916635
[No Abstract] [Full Text] [Related]
16. Antitrust--pre-merger compliance.
Brock TH
Health Syst Rev; 1993; 26(6):36-8. PubMed ID: 10130173
[TBL] [Abstract][Full Text] [Related]
17. Economic analysis in health care antitrust.
Vita MG; Langenfeld J; Pautler P; Miller L
J Contemp Health Law Policy; 1991; 7():73-115. PubMed ID: 10111250
[TBL] [Abstract][Full Text] [Related]
18. Antitrust issues in the settlement of pharmaceutical patent disputes, Part II.
Leary TB
J Health Law; 2001; 34(4):657-71. PubMed ID: 11833411
[TBL] [Abstract][Full Text] [Related]
19. Protecting competition and consumers: a conversation with Timothy J. Muris. Interview by William Sage.
Muris TJ
Health Aff (Millwood); 2003; 22(6):101-10. PubMed ID: 14649436
[TBL] [Abstract][Full Text] [Related]
20. Does your physician network violate antitrust law?. Interview by Michael Pretzer.
Pitofsky R
Med Econ; 1996 Oct; 73(19):68-70, 73-6, 79. PubMed ID: 10162456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
